SCHEMBL9786714

SCHEMBL9786714

CCc1[nH]c(=S)[nH]c1C(=O)Nc1ccccn1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.54
▸ RAB9A P51151 5/20 0.54
▸ ALDH1A1 P00352 4/20 0.50
▸ GAA P10253 3/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ MEN1 O00255 4/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ RXFP1 Q9HBX9 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ MAPK1 P28482 1/20 0.45
▸ PKM P14618 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ F2 P00734 1/20 0.44
▸ TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10595089 0.86 NPC1 (0.55) NPC1RAB9AALDH1A1GAAL3MBTL1
SCHEMBL10805915 0.73 CYP1A2 (0.49) RAB9AALDH1A1GAAMEN1KMT2A
SCHEMBL2726850 0.71 MEN1 (0.65) NPC1RAB9AGAAL3MBTL1MEN1
SCHEMBL31277641 0.70 GRM5 (0.56) NPC1RAB9AALDH1A1GAAL3MBTL1
SCHEMBL10930572 0.70 NPC1 (0.50) NPC1RAB9AGAAL3MBTL1MEN1
SCHEMBL10162070 0.70 NPC1 (0.76) NPC1RAB9AGAAL3MBTL1MEN1
SCHEMBL30071250 0.68 GAA (0.76) NPC1RAB9AALDH1A1GAAMEN1
SCHEMBL626827 0.68 GAA (0.76) NPC1RAB9AALDH1A1GAAMEN1
SCHEMBL9384187 0.67 NPC1 (0.72) NPC1RAB9AALDH1A1GAAL3MBTL1
SCHEMBL519066 0.67 RAB9A (0.73) NPC1RAB9AALDH1A1GAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5002961-A Antiischemic Agents, Preventing Reperfusion Injuries MERRELL DOW PHARMACEUTICALS (US) 1991-03-26 — — US disclosed
EP-0312960-A2 Method for reducing reperfusion injury with imidazol-2-thione-carboxamides MERRELL DOW PHARMACEUTICALS INC. (US) 1989-04-26 — — EP disclosed
Send feedback